Clinical Research of the Rockies
Lafayette, Colorado 80026
0 studies enrolling now · 11 studies all time
What they study most
Colitis, Ulcerative, Crohn's Disease, Diverticulitis, Irritable Bowel Syndrome, Ulcerative Colitis
Studies at this site
- Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies — Stopped early
- A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors — Completed
- Prevention of Recurrence of Diverticulitis — Completed
- A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis — Completed
- A Study To Monitor Long-Term Treatment With PF-00547659 — Completed
- Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease — Completed
- A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease — Completed
- A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease — Completed
- The Safety And Efficacy Of Maintenance Therapy With CP-690,550 — Completed
- A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis — Completed
- LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) — Completed